Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Coppo

Showing results (181-190 of 199) with videos related to

Pageof 20
Sort By:
Blood|November 5, 2020
A regimen with caplacizumab, immunosuppression, and plasma exchange prevents unfavorable outcomes in immune-mediated TTPPaul Coppo, Michael Bubenheim, Elie Azoulay, et al.
American Journal of Hematology|July 15, 2025
Anti-ADAMTS13 Antibodies Trajectory is Associated With ADAMTS13 Recovery in Immune-Mediated TTPMarie Robert, Arthur Mageau, Ygal Benhamou, et al.
Blood|May 2, 2020
Open ADAMTS13, induced by antibodies, is a biomarker for subclinical immune-mediated thrombotic thrombocytopenic purpuraElien Roose, An-Sofie Schelpe, Edwige Tellier, et al.
Kidney International|March 2, 2024
Assessment of epidemiology and outcomes of adult patients with kidney-limited thrombotic microangiopathiesValentin Maisons, Anna Duval, Laurent Mesnard, et al.
The Journal of Allergy and Clinical Immunology. in Practice|October 16, 2023
Efficacy and Safety of Rituximab-Based Treatments in Angioedema With Acquired C1-Inhibitor DeficiencyGalith Kalmi, Yann Nguyen, Stephanie Amarger, et al.
Emerging Infectious Diseases|June 21, 2021
Shiga Toxin-Associated Hemolytic Uremic Syndrome in Adults, France, 2009-2017Benoît Travert, Antoine Dossier, Matthieu Jamme, et al.
Blood|September 19, 2019
Immune thrombotic thrombocytopenic purpura in older patients: prognosis and long-term survivalRenaud Prevel, Claire Roubaud-Baudron, Samuel Gourlain, et al.
Journal of Neurology|July 1, 2023
Predictors of acute ischemic cerebral lesions in immune-mediated thrombotic thrombocytopenic purpura and hemolytic uremic syndromeLisa Neuman, Adrien Joseph, Raïda Bouzid, et al.
Haematologica|May 15, 2012
Development and validation of a predictive model for death in acquired severe ADAMTS13 deficiency-associated idiopathic thrombotic thrombocytopenic purpura: the French TMA Reference Center experienceYgal Benhamou, Cyrielle Assié, Pierre-Yves Boelle, et al.
American Journal of Hematology|December 11, 2020
First-line treatment of double-hit and triple-hit lymphomas: Survival and tolerance data from a retrospective multicenter French studyMarie-Charlotte Laude, Laure Lebras, Pierre Sesques, et al.
Pageof 20

Showing results (181-190 of 199) with videos related to

Sort By:
Pageof 20
Blood|November 5, 2020
A regimen with caplacizumab, immunosuppression, and plasma exchange prevents unfavorable outcomes in immune-mediated TTPPaul Coppo, Michael Bubenheim, Elie Azoulay, et al.
American Journal of Hematology|July 15, 2025
Anti-ADAMTS13 Antibodies Trajectory is Associated With ADAMTS13 Recovery in Immune-Mediated TTPMarie Robert, Arthur Mageau, Ygal Benhamou, et al.
Blood|May 2, 2020
Open ADAMTS13, induced by antibodies, is a biomarker for subclinical immune-mediated thrombotic thrombocytopenic purpuraElien Roose, An-Sofie Schelpe, Edwige Tellier, et al.
Kidney International|March 2, 2024
Assessment of epidemiology and outcomes of adult patients with kidney-limited thrombotic microangiopathiesValentin Maisons, Anna Duval, Laurent Mesnard, et al.
The Journal of Allergy and Clinical Immunology. in Practice|October 16, 2023
Efficacy and Safety of Rituximab-Based Treatments in Angioedema With Acquired C1-Inhibitor DeficiencyGalith Kalmi, Yann Nguyen, Stephanie Amarger, et al.
Emerging Infectious Diseases|June 21, 2021
Shiga Toxin-Associated Hemolytic Uremic Syndrome in Adults, France, 2009-2017Benoît Travert, Antoine Dossier, Matthieu Jamme, et al.
Blood|September 19, 2019
Immune thrombotic thrombocytopenic purpura in older patients: prognosis and long-term survivalRenaud Prevel, Claire Roubaud-Baudron, Samuel Gourlain, et al.
Journal of Neurology|July 1, 2023
Predictors of acute ischemic cerebral lesions in immune-mediated thrombotic thrombocytopenic purpura and hemolytic uremic syndromeLisa Neuman, Adrien Joseph, Raïda Bouzid, et al.
Haematologica|May 15, 2012
Development and validation of a predictive model for death in acquired severe ADAMTS13 deficiency-associated idiopathic thrombotic thrombocytopenic purpura: the French TMA Reference Center experienceYgal Benhamou, Cyrielle Assié, Pierre-Yves Boelle, et al.
American Journal of Hematology|December 11, 2020
First-line treatment of double-hit and triple-hit lymphomas: Survival and tolerance data from a retrospective multicenter French studyMarie-Charlotte Laude, Laure Lebras, Pierre Sesques, et al.
Pageof 20